GT737
Relapsed/Refractory Acute Myeloid Leukemia (AML)
Grit BiotechnologyEarly Phase 1
—
Rating in progress
GT737 in Relapsed/Refractory Acute Myeloid Leukemia (AML) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active